1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine

C23H34ClN5O — CID 111762597

IUPAC1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine
SMILESCCN/C(=N\CC1CCN(Cc2nc(C)c(C)o2)CC1)NCCc1ccc(Cl)cc1
InChIInChI=1S/C23H34ClN5O/c1-4-25-23(26-12-9-19-5-7-21(24)8-6-19)27-15-20-10-13-29(14-11-20)16-22-28-17(2)18(3)30-22/h5-8,20H,4,9-16H2,1-3H3,(H2,25,26,27)
InChIKeyJFUNJJREKBSOGY-UHFFFAOYSA-N
MW432.01 g/mol
LogP3.95
Rot. Bonds8

About 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine

1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine (PubChem CID 111762597) has the molecular formula C23H34ClN5O and a molecular weight of 432.01 g/mol. Its IUPAC name is 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine.

Molecular Properties

Compound Name1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine
PubChem CID111762597
Molecular FormulaC23H34ClN5O
Molecular Weight432.01 g/mol
Exact Mass431.25
IUPAC Name1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine
SMILESCCN/C(=N\CC1CCN(Cc2nc(C)c(C)o2)CC1)NCCc1ccc(Cl)cc1
InChIInChI=1S/C23H34ClN5O/c1-4-25-23(26-12-9-19-5-7-21(24)8-6-19)27-15-20-10-13-29(14-11-20)16-22-28-17(2)18(3)30-22/h5-8,20H,4,9-16H2,1-3H3,(H2,25,26,27)
InChIKeyJFUNJJREKBSOGY-UHFFFAOYSA-N
XLogP3.95
TPSA65.69 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500432.01
LogP ≤ 53.95
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine?
The IUPAC name of 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine (CID 111762597) is 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine.
What is the SMILES notation for 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine?
The canonical SMILES for 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine is CCN/C(=N\CC1CCN(Cc2nc(C)c(C)o2)CC1)NCCc1ccc(Cl)cc1.
What is the InChIKey of 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine?
The InChIKey is JFUNJJREKBSOGY-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H34ClN5O/c1-4-25-23(26-12-9-19-5-7-21(24)8-6-19)27-15-20-10-13-29(14-11-20)16-22-28-17(2)18(3)30-22/h5-8,20H,4,9-16H2,1-3H3,(H2,25,26,27).
What are the key properties of 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine?
1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine has a molecular weight of 432.01 g/mol, XLogP of 3.95, 8 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[2-(4-chlorophenyl)ethyl]-2-[[1-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperidin-4-yl]methyl]-3-ethylguanidine is sourced from PubChem (CID 111762597), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).